Analysts generally believe that whether from the index component or from the capital increment, the significance of entering the mainstream index of science and technology innovation board is very important.
If we refer to the S & P 500 index, the proportion of technology consumption in this index is higher than that of non-financial tertiary industry (60%) in the U.S. economy, while the proportion of Hushen 300 index is less than that of domestic non-financial tertiary industry (50%). Therefore, there is still much room for structural adjustment of Shanghai Shenzhen 300 and other A-share important indexes.
According to the above-mentioned securities companies, the main index is expected to absorb leading technology companies such as SMIC international and Jinshan office, which will truly reflect the achievements of Chinas economic transformation from old to new and economic structure transformation, provide investors with high-quality returns, and help the first round of long bull in A-share history.
At the same time, this decision also further reflects the states attention to the capital market, especially the science and technology innovation board.
This reform promotes the status of the science and technology innovation board, and helps the science and technology innovation enterprises not only make use of the high-quality industry support policy, but also quickly land in the capital market for financing, and can obtain the international status close to the Hong Kong stock market and even other overseas markets.
For foreign investors, many of Chinas advantageous assets in the science and technology innovation board are unique in the global market. Foreign investment in science and technology innovation board has gone from no door to open door in the past.
On the one hand, the inclusion of a series of core indexes further highlights the investment value of high-quality science and technology innovation standards, and the first to be included in the science and technology innovation standards will also obtain the joint allocation of related broad-based ETFs;
On the other hand, Shanghai Stock Exchange 180 and Shanghai Stock Exchange 380 are the basis for the inclusion of the list of Shanghai Stock connect. Moreover, the Shanghai Shenzhen Hong Kong Stock Exchange has also decided recently that the science and Technology Innovation Board companies that belong to the Shanghai Stock Exchange 180, Shanghai 380 index or a + H share company will be transferred into the stock scope of Shanghai Stock connect according to the existing provisions of Shanghai Stock connect, and its corresponding H shares will be transferred into the stock scope of Hong Kong stock connect according to the existing provisions of Shanghai Shenzhen Stock connect The first batch of companies included in the science and technology innovation board are also expected to be included in the list of Shanghai Stock connect and receive additional foreign investment.
According to the data, there are four science and technology innovation board stocks that meet the requirements for inclusion in the Shanghai Shenzhen 300 index, namely, LanChi technology, China Unicom, medium and micro companies and voice holding; medium and micro companies can also be included in the Shanghai Stock Exchange 180 index.
LanChi technology, RuiChuang micro nano, Western superconductor, Haier biology, Anji technology and Hangke technology are qualified to be included in the Shanghai Stock Exchange 380 index.
It is worth noting that the first batch of companies approved to be included in the core index of Shanghai Stock Exchange are mainly from the information technology industry.
In addition, 5 can be included in the CSI 500 index, including RuiChuang micro nano, Nanwei medicine, hongruan technology, Jingchen Co., Ltd., and microchip; 19 can be included in the CSI 1000 index, such as Lexin technology, rongbai technology, Sinochem and Jiayuan technology. Source: Wall Street news editor: Yang Bin_ NF4368
In addition, 5 can be included in the CSI 500 index, including RuiChuang micro nano, Nanwei medicine, hongruan technology, Jingchen Co., Ltd., and microchip; 19 can be included in the CSI 1000 index, such as Lexin technology, rongbai technology, Sinochem and Jiayuan technology.